Insider filing · RCUS
Carolyn C. Tang
General Counsel
profile →
Arcus Biosciences, Inc.
RCUS · Healthcare · 21 filings in 24 months
ticker →
Carolyn C. Tang sold $318K of Arcus Biosciences (RCUS)
Executed Dec 16 2025, disclosed Dec 18 2025, 2 days later.
Value, as filed
$318K
14,468 sh across 2 lots
Executed
Dec 16 2025
the trade date, as filed
Disclosed
Dec 18 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CTCarolyn C. Tang (General Counsel) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Arcus Biosciences, Inc. (RCUS). The largest single filing was $318K of RCUS (14,468 sh across 2 lots, as filed), executed Dec 16 2025.
The name
RCUSHealthcare · Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→